DalsnaFinance › IPOs › Anebulo Pharmaceuticals › IPO
Anebulo Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on May 7, 2021, pricing at $7.00 a share.
| Ticker | ANEB |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 7, 2021 |
| Offering price | $7.00 |
| Shares offered | 3,000,000 |
| Total raised | $21M |
Anebulo Pharmaceuticals, Inc. sold 3,000,000 shares at $7.00 each on NASDAQ. Multiplied out, that is $21 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $21 million total recorded for the deal.
Anebulo Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Anebulo Pharmaceuticals, Inc.. This page is general information, not investment advice.